Catalysts

WHITE PAPERS AND CASE STUDIES

• Pasteurized Equivalent Water Treatment At High Desert Milk, Idaho, US

  Learn how High Desert Milk, a cooperative in Idaho, optimized their water treatment process using HOD™ UV technology, ensuring FDA compliance while significantly reducing water and energy consumption.

• Vaccine Trial Sees >90% eCOA Adherence

  Discover how we addressed vaccine trial challenges and drove remarkable success, achieving over 90% adherence to eCOA, ensuring active engagement from the trial participants, and yielding consistent, reliable trial data.

• 82 Million Gallons In. Zero PFAS Out.

  Ion exchange resin is a reliable, high-capacity solution for municipal PFAS treatment, demonstrating zero detectable PFAS after processing 82 million gallons of water. The technology offers a significantly smaller footprint and superior volumetric capacity compared to GAC. Read the full case study to review performance data and strategic impacts.

• Modelling TPDs Utilizing Computational And Medicinal Chemistry Approaches

  Through a carefully executed strategy, see how we identified novel degrader molecules with the right physicochemical properties to achieve robust degradation of the target Protein of Interest (POI).

• SL-RAT At Little Rock Water Reclamation Authority

  Little Rock looked to enhance their sophisticated cleaning program and reduce sanitary sewer overflow count by implementing new technologies.

• Optimizing Chronic Cough Phase 3 Trials With Point-Of-Need Eye Assessments

  Collaboration was key for Company W to overcome challenges with an FDA-mandated ocular substudy, including limited resources for ocular assessments and logistical difficulties

• Leeton Shire Improves Efficiency And Service Levels With An Affordable, Intuitive Digital Solution

  Although Leeton Shire already had some digital technologies in place, such as SCADA, GIS and AMI, they lacked hydraulic modeling capabilities and expertise — which is why they turned to Qatium’s open and secure water management platform.

• Using eConsent Data To Populate Site And Sponsor Data Systems

  A top-10 pharmaceutical company was looking to reduce the amount of administrative burden on their clinical trial sites and themselves. See how we accomplished it, using eConsent.

• Standardize Flow Cytometry Data With Easy Assay Transfer Across Sites

  Gain insight into how a global pharmaceutical company successfully transferred their cell therapy assays across international locations.

• Driving A High-Adherence LTFU Trial Without An EDC

  Discover how our partnership with a client was able to deliver a ten-year long-term follow-up (LTFU) trial that delivered an over 90% adherence rate while keeping trial costs low by not using an EDC.

• Generation Of A Contamination Control Strategy

  An unaddressed compliance issue related to contamination control can pose a significant risk to a life sciences organization. This case study details a company's journey toward sustainable compliance.

• Rapid Assessment Of Fab-VHH Expression

  Find out how a 10-day expression screening program rapidly identified optimal gene orientation for a bi-specific antibody fragment fusion, achieving up to 570 µg/mL soluble, active product.